Product Comparison


 
Sanofi Pasteur 00024582411
APP Pharmaceuticals 63323011710
Fresenius USA 63323011751
Fresenius USA 63323012310

No Image

McKesson # 741858 479124 788329 652633 1129996
Description Jevtana® Cabazitaxel 60 mg / 1.5 mL Intravenous Injection Single Dose Vial 1.5 mL Fluorouracil 50 mg / mL Intravenous Injection Single Dose Vial 10 mL Fluorouracil 50 mg / mL Intravenous Injection Pharmacy Bulk Vial 50 mL Methotrexate Sodium 25 mg / mL Intramuscular, Intravenous, or Intra-arterial Injection Multiple Dose Vial 10 mL 15 Units Injection Single Dose Vial
Manufacturer # 0002458241163323011710633230117516332301231016714088601
Brand Jevtana┬«    
Manufacturer Sanofi PasteurAPP PharmaceuticalsFresenius USAFresenius USANorth Star Rx
Invoice JEVTANA INJ+DIL, SDV 60MG/1.5 ML 1.5MLFLUOROURACIL, SDV 50MG/ML 10ML(10/CT)FLUOROURACIL, VL 2.5GM/50ML 50MLMETHOTREXATE, MDV 25MG/ML 10MLBLEOMYCIN, SDV 15UNIT
    Log In to Order   Log In to Order   Log In to Order   Log In to Order   Log In to Order

Comparison

Alternate Manufacturer Number 19277301327261128152622296073409893
Container Type Single Dose VialSingle Dose VialPharmacy Bulk VialMultiple Dose VialSingle Dose Vial
Generic Drug Code 28762974559745738466
Generic Drug Name CabazitaxelFluorouracilFluorouracilMethotrexate Sodium
NDC Number 00024-5824-1163323-0117-1063323-0117-5163323-0123-1016714088601
Storage Requirements USP Controlled Room TemperatureRequires Refrigeration
Strength 60 mg / 1.5 mL50 mg / mL50 mg / mL25 mg / mL15 Units
Type IntravenousIntravenousIntravenousIntramuscular, Intravenous, or Intra-arterial
UNSPSC Code 5111172851442004514420045120220351111733
Volume 1.5 mL10 mL50 mL10 mL
Application Antineoplastic AgentAntineoplastic AgentAntineoplastic AgentAntineoplastic AgentAntineoplastic Agent
Country of Origin UnknownUnknownUnknownUnknownUnknown
Dosage Form InjectionInjectionInjectionInjectionInjection
Product Dating McKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 days
Features and Benefits
  • JEVTANA is a microtubule inhibitor indicated in combination with prednisone for treatment of patients with hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing treatment regimen
  • JEVTANA is supplied as a kit containing one single-use vial of JEVTANA (cabazitaxel) Injection (clear glass vial with a grey rubber closure, aluminum cap and light green plastic flip-off cap) and one vial of Diluent for JEVTANA (13% (w/w) ethanol in water for injection) in a clear glass vial with a grey rubber closure, gold-color aluminum cap and colorless plastic flip-off cap
  • JEVTANA requires two dilutions prior to administration
  • First diluted solution of JEVTANA should be used immediately (within 30 minutes)
  • Fully prepared JEVTANA infusion solution (in either 0.9% sodium chloride solution or 5% dextrose solution) should be used within 8 hours at ambient temperature (including the one-hour infusion), or for a total of 24 hours (including the one-hour infusion) under the refrigerated conditions
  • PVC equipment should not be used
  • Contains preservative
  • Sterile Isotonic Liquid
  • Not for intrathecal use